Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.

Melinda L HsuJoseph C MurrayKevin J PsoterJiajia ZhangDurrant BarasaJulie R BrahmerDavid S EttingerPatrick M FordeChristine L HannVincent K LamBenjamin LevyKristen A MarroneTricia PatelValerie PetersonSarah SagorskyMichelle TurnerValsamo AnagnostouJarushka NaidooJosephine L Feliciano

Published in: The oncologist (2022)

Significant proportions of ICI survivors have unresolved long-term toxicities. These data support a growing need to understand long-term toxicity to optimize management of those treated with ICIs.

Keyphrases

young adults
oxidative stress
electronic health record
risk factors
newly diagnosed
artificial intelligence
deep learning